Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mei Pharma Inc (MEIP)

Mei Pharma Inc (MEIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Income Statement for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 06/30

(Values in U.S. thousands)
  06-2013 06-2012 06-2011 06-2010 06-2009
Operating Expenses 11,222 8,394 6,451 7,979 11,407
Operating Income -11,222 -8,394 -6,451 -7,979 -11,407
Other Income 37 872 -329 84 226
Pre-tax Income -11,185 -7,522 -6,780 -7,895 -11,181
Income Tax 1 -1 -1 1 1
Net Income Continuous -11,186 -7,521 -6,779 -7,896 -11,182
Net Income $-11,186 $-7,521 $-6,779 $-7,896 $-11,182
EPS Basic Total Ops -22.00 -67.00 -106.78 -128.37 -183.56
EPS Basic Continuous Ops -22.02 -66.91 -106.41 -128.96 -183.60
EPS Diluted Total Ops -22.00 -67.00 -106.78 -128.37 -183.56
EPS Diluted Continuous Ops -22.02 -66.91 -106.41 -128.96 -183.60
EBITDA(a) $-11,177 $-8,381 $-6,438 $-7,979 $-11,407
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar